Skip to main content
Premium Trial:

Request an Annual Quote

Canon Medical Systems Acquires Majority Stake in Cancer Genomic Profiling JV

NEW YORK (GenomeWeb) — Canon Medical Systems has completed its acquisition of a majority stake in ACTmed, a Japanese joint venture established with Taiwanese molecular diagnostics firm ACT Genomics (ACTG), ACTG said today.

As part of the transaction, ACTG will transfer its clinical next-generation sequencing technology — which includes its flagship ACTOnco+ assay for determining the mutational status of solid tumors and guiding treatment selection — to ACTmed. ACTG has also agreed to support ACTmed's cancer genomic profiling operations in Japan and provide it with sequencing data analysis services.

Additional details were not disclosed.